Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran

INTRODUCTION: Ceftazidime avibactam (CA) is an effective treatment against carbapenem-resistant Enterobacteriaceae (CRE), but its cost-effectiveness is unclear. This study was performed to evaluate the cost-effectiveness of CA against the best available treatment colistin (Col) for patients with CRE...

Descripción completa

Detalles Bibliográficos
Autores principales: Goudarzi, Zahra, Danayi, Fattaneh, Keshavarz, Khosro, Gholami, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364345/
https://www.ncbi.nlm.nih.gov/pubmed/37482610
http://dx.doi.org/10.1186/s12962-023-00454-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364345/
https://www.ncbi.nlm.nih.gov/pubmed/37482610
http://dx.doi.org/10.1186/s12962-023-00454-8

Ejemplares similares